Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity

Stylianos BournazosJeffrey V Ravetch


Broadly neutralizing antibodies (bNAbs) against HIV-1 provide both effective pre-exposure prophylaxis and treatment of HIV-1 infection in murine and nonhuman primate models, suggesting their potential use in humans. Although much is known about the role of variable domains in the neutralization breadth and potency of these bNAbs, the contribution of Fc domains to their activities is, by contrast, poorly characterized. Assessment of the in vivo activity of several bNAbs revealed that FcγR-mediated effector function contributes substantially to their capacity to block viral entry, suppress viremia, and confer therapeutic activity. Enhanced in vivo potency of anti-HIV-1 bNAbs was associated with preferential engagement of activating, but not inhibitory FcγRs, and Fc domain-engineered bNAb variants with selective binding capacity for activating FcγRs displayed augmented protective activity. These findings reveal key roles for Fc effector function in the in vivo activity of anti-HIV-1 bNAbs and provide strategies for generating bNAbs with improved efficacy.


Aug 16, 2003·Science·Hedda WardemannMichel C Nussenzweig
Dec 3, 2005·Science·Falk Nimmerjahn, Jeffrey V Ravetch
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Greg A LazarBassil I Dahiyat
Aug 4, 2010·The Journal of Experimental Medicine·John PietzschMichel C Nussenzweig
Oct 6, 2010·The Journal of Experimental Medicine·Nareen AbboudArturo Casadevall
Jul 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Arturo Casadevall, Alena Janda
Sep 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·John PietzschMichel C Nussenzweig
Nov 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hugo MouquetPamela J Bjorkman
May 29, 2013·The Journal of Experimental Medicine·Ron DiskinPamela J Bjorkman
Sep 14, 2013·Science·Florian KleinMichel C Nussenzweig
Sep 18, 2013·Proceedings of the National Academy of Sciences of the United States of America·Joshua A HorwitzMichel C Nussenzweig
Jan 10, 2014·The Journal of Clinical Investigation·Stylianos BournazosJeffrey V Ravetch
Jul 22, 2014·Nature Immunology·Andrew PinceticJeffrey V Ravetch

❮ Previous
Next ❯


Oct 25, 2014·Nature·Alexandra Trkola
Aug 19, 2015·The Journal of Experimental Medicine·Stylianos BournazosJeffrey V Ravetch
Feb 11, 2016·Journal of Translational Medicine·Paul W DentonMartin Tolstrup
Feb 7, 2016·Journal of Structural Biology·Alysia A AhmedPamela J Bjorkman
Feb 5, 2016·Current HIV/AIDS Reports·Kathryn E Stephenson, Dan H Barouch
Jan 15, 2016·Biosensors & Bioelectronics·András HushegyiJan Tkac
Jan 12, 2016·The Journal of Clinical Investigation·Ariel Halper-Stromberg, Michel C Nussenzweig
Jul 28, 2015·Structure·Ganesh P Subedi, Adam W Barb
Sep 30, 2015·Proceedings of the National Academy of Sciences of the United States of America·Andreas LoosLukas Mach
Dec 29, 2015·Current Opinion in Pediatrics·Kaitlin Rainwater-LovettDeborah Persaud
Mar 5, 2016·Nature Communications·Timothée BruelOlivier Schwartz
Oct 5, 2015·Trends in Microbiology·Mireia PelegrinMarc Piechaczyk
Mar 24, 2016·Current HIV/AIDS Reports·Eileen Scully, Galit Alter
Feb 11, 2015·Journal of Immunological Methods·Natalia T FreundMichel C Nussenzweig
Apr 5, 2016·Proceedings of the National Academy of Sciences of the United States of America·Larry ZeitlinThomas W Geisbert
Aug 11, 2015·Frontiers in Immunology·Gunnveig GrødelandBjarne Bogen
Jul 22, 2015·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Sarah CobeyFrederick A Matsen
May 16, 2015·Cell·David J DiLillo, Jeffrey V Ravetch
May 7, 2015·Mayo Clinic Proceedings·Nathan W Cummins, Andrew D Badley
May 20, 2015·Nature Immunology·Dennis R Burton, John R Mascola
Mar 24, 2016·Pathogens and Disease·Alan Schmaljohn, George K Lewis
Feb 19, 2015·Immunity·Taia T Wang, Jeffrey V Ravetch
Mar 3, 2015·Current Opinion in HIV and AIDS·Ann J Hessell, Nancy L Haigwood
Feb 24, 2015·Current Opinion in HIV and AIDS·Austin W BoeschMargaret E Ackerman
May 12, 2016·Annual Review of Immunology·Dennis R Burton, Lars Hangartner
Jan 20, 2016·Expert Review of Vaccines·Joshua J GlassRobert De Rose
May 20, 2016·Medical Microbiology and Immunology·Eugenia Corrales-AguilarHartmut Hengel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.